On February 21, 2017: issued by the ministry of agriculture of the People's Republic of China "restructuring (H5 subtype avian influenza virus bivalent inactivated vaccine (cell source, Re - 6 strains + Re - 8 strains) approval documents of approval for veterinary drug products.